Literature DB >> 3083509

A neuronal antigen in the brains of Alzheimer patients.

B L Wolozin, A Pruchnicki, D W Dickson, P Davies.   

Abstract

A monoclonal antibody was prepared against pooled homogenates of brain tissue from patients with Alzheimer's disease. This antibody recognizes an antigen present in much higher concentration in certain brain regions of Alzheimer patients than in normal brain. The antigen appears to be a protein present in neurons involved in the formation of neuritic plaques and neurofibrillary tangles, and in some morphologically normal neurons in sections from Alzheimer brains. Partial purification and Western blot analysis revealed the antigen from Alzheimer brain to be a single protein with a molecular weight of 68,000. Application of the same purification procedure to normal brain tissue results in the detection of small amounts of a protein of lower molecular weight.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083509     DOI: 10.1126/science.3083509

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  146 in total

Review 1.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

2.  Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease.

Authors:  R B Knowles; C Wyart; S V Buldyrev; L Cruz; B Urbanc; M E Hasselmo; H E Stanley; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.

Authors:  D W Dickson; H Ksiezak-Reding; W K Liu; P Davies; A Crowe; S H Yen
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Demonstration using the hydrated autoclaving method.

Authors:  R W Shin; T Iwaki; T Kitamoto; Y Sato; J Tateishi
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

5.  Senile plaques, amyloid beta-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex.

Authors:  T G Beach; E G McGeer
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine.

Authors:  K Shigematsu; P L McGeer
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

7.  Production of a bi-specific monoclonal antibody recognizing mouse kappa light chains and horseradish peroxidase. Applications in immunoassays.

Authors:  R L Kenigsberg; A C Cuello
Journal:  Histochemistry       Date:  1990

Review 8.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

9.  Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.

Authors:  V Askanas; W K Engel; M Bilak; R B Alvarez; D J Selkoe
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

10.  Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.

Authors:  T Kawamata; I Tooyama; T Yamada; D G Walker; P L McGeer
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.